Applied Nutrition readies for IPO and £500m valuation

Andy Bell, chair of Applied Nutrition

Merseyside-based Applied Nutrition has confirmed it is “actively preparing” for an initial public offering (IPO) of shares on the London stock market at the end of the year in a move that could value the group at a reported £500 million.

Applied Nutrition, which is backed by sportswear retailer JD Sports Fashion, said it was looking to launch its IPO in the final quarter of 2024, depending on market conditions.

The firm said it has been “actively preparing for IPO on the main market” with reports suggesting the listing would value Applied Nutrition at around £500 million, which would potentially land it a place in the FTSE 250 Index.

Applied Nutrition has been beefing up its board ahead of the expected IPO, hiring Aaron Heidebreicht as US chief executive in March and appointing AJ Bell founder Andy Bell as its chairman.

It is understood that Applied Nutrition founder and group CEO Tom Ryder is planning to sell down his 55% stake to 30% as part of the IPO.

The IPO would also come as a boost to the London Stock Exchange after a raft of UK firms have been bought by foreign rivals and a number of companies have also switched their listings away from London.

Ryder said that while the IPO timing is not yet “certain”, it has held “positive” meetings with investors.

It came as the group reported a 41% jump in annual underlying earnings to £26 million in the year to July 31 on sales up 42% to £86.2 million.

Ryder said: “This has been another standout year for Applied Nutrition, continuing our growth journey through increasing our international penetration, delivering new products and further diversifying our routes to market …

“To support our ambitious plans in the coming years, we continue to lay the groundwork ahead of our potential IPO on the London Stock Exchange later this year.

“We believe London is an exceptional home for growth companies and if everything falls into place, we hope to deliver another successful IPO to the London market.

“Nothing is certain in this climate, but meetings with investors have so far been positive and we’re delighted by the enthusiasm shown for our story.”